nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafcillin—CYP1A2—chronic obstructive pulmonary disease	0.606	1	CbGaD
Nafcillin—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0738	0.257	CbGbCtD
Nafcillin—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.06	0.209	CbGbCtD
Nafcillin—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0405	0.141	CbGbCtD
Nafcillin—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0386	0.135	CbGbCtD
Nafcillin—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0344	0.12	CbGbCtD
Nafcillin—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0202	0.0705	CbGbCtD
Nafcillin—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0191	0.0666	CbGbCtD
Nafcillin—Skin necrosis—Aminophylline—chronic obstructive pulmonary disease	0.00512	0.0514	CcSEcCtD
Nafcillin—Tongue discolouration—Salbutamol—chronic obstructive pulmonary disease	0.00266	0.0267	CcSEcCtD
Nafcillin—Extravasation—Aminophylline—chronic obstructive pulmonary disease	0.00205	0.0206	CcSEcCtD
Nafcillin—Skin exfoliation—Aminophylline—chronic obstructive pulmonary disease	0.00171	0.0171	CcSEcCtD
Nafcillin—Phlebitis—Aminophylline—chronic obstructive pulmonary disease	0.00151	0.0151	CcSEcCtD
Nafcillin—Inflammation—Formoterol—chronic obstructive pulmonary disease	0.0014	0.0141	CcSEcCtD
Nafcillin—Inflammation—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.0141	CcSEcCtD
Nafcillin—Inflammation—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.0133	CcSEcCtD
Nafcillin—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.00109	0.0109	CcSEcCtD
Nafcillin—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00107	0.0108	CcSEcCtD
Nafcillin—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.00106	0.0106	CcSEcCtD
Nafcillin—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.000998	0.01	CcSEcCtD
Nafcillin—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000986	0.0099	CcSEcCtD
Nafcillin—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.000954	0.00958	CcSEcCtD
Nafcillin—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.000927	0.00931	CcSEcCtD
Nafcillin—Stomatitis—Tiotropium—chronic obstructive pulmonary disease	0.00092	0.00924	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000872	0.00875	CcSEcCtD
Nafcillin—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.000871	0.00875	CcSEcCtD
Nafcillin—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.00084	0.00844	CcSEcCtD
Nafcillin—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.00084	0.00844	CcSEcCtD
Nafcillin—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.000828	0.00832	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000826	0.0083	CcSEcCtD
Nafcillin—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.000793	0.00797	CcSEcCtD
Nafcillin—CYP1A2—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00079	0.102	CbGpPWpGaD
Nafcillin—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000788	0.00792	CcSEcCtD
Nafcillin—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000782	0.00786	CcSEcCtD
Nafcillin—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00076	0.00763	CcSEcCtD
Nafcillin—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000756	0.0076	CcSEcCtD
Nafcillin—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.000726	0.00729	CcSEcCtD
Nafcillin—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.000726	0.00729	CcSEcCtD
Nafcillin—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000705	0.00708	CcSEcCtD
Nafcillin—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.000701	0.00704	CcSEcCtD
Nafcillin—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00069	0.089	CbGpPWpGaD
Nafcillin—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.000685	0.00688	CcSEcCtD
Nafcillin—Necrosis—Prednisone—chronic obstructive pulmonary disease	0.000682	0.00685	CcSEcCtD
Nafcillin—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000674	0.00677	CcSEcCtD
Nafcillin—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000655	0.00657	CcSEcCtD
Nafcillin—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000638	0.00641	CcSEcCtD
Nafcillin—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000628	0.0063	CcSEcCtD
Nafcillin—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000628	0.0063	CcSEcCtD
Nafcillin—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000628	0.0063	CcSEcCtD
Nafcillin—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.000618	0.00621	CcSEcCtD
Nafcillin—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00061	0.0787	CbGpPWpGaD
Nafcillin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000608	0.00611	CcSEcCtD
Nafcillin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000603	0.00606	CcSEcCtD
Nafcillin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000603	0.00605	CcSEcCtD
Nafcillin—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000596	0.00599	CcSEcCtD
Nafcillin—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000592	0.00595	CcSEcCtD
Nafcillin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000568	0.00571	CcSEcCtD
Nafcillin—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000552	0.00554	CcSEcCtD
Nafcillin—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000552	0.00554	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000548	0.00551	CcSEcCtD
Nafcillin—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000544	0.00546	CcSEcCtD
Nafcillin—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000544	0.00546	CcSEcCtD
Nafcillin—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000537	0.00539	CcSEcCtD
Nafcillin—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000537	0.00539	CcSEcCtD
Nafcillin—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000533	0.00535	CcSEcCtD
Nafcillin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000522	0.00524	CcSEcCtD
Nafcillin—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000521	0.00524	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000519	0.00522	CcSEcCtD
Nafcillin—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000513	0.00516	CcSEcCtD
Nafcillin—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000511	0.00514	CcSEcCtD
Nafcillin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000507	0.00509	CcSEcCtD
Nafcillin—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000507	0.00509	CcSEcCtD
Nafcillin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000507	0.00509	CcSEcCtD
Nafcillin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000507	0.00509	CcSEcCtD
Nafcillin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000507	0.00509	CcSEcCtD
Nafcillin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000507	0.00509	CcSEcCtD
Nafcillin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000504	0.00507	CcSEcCtD
Nafcillin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000504	0.00507	CcSEcCtD
Nafcillin—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.0005	0.00503	CcSEcCtD
Nafcillin—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.0005	0.00503	CcSEcCtD
Nafcillin—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000499	0.0643	CbGpPWpGaD
Nafcillin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000496	0.00498	CcSEcCtD
Nafcillin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000496	0.00498	CcSEcCtD
Nafcillin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000492	0.00494	CcSEcCtD
Nafcillin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000486	0.00488	CcSEcCtD
Nafcillin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000486	0.00488	CcSEcCtD
Nafcillin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000478	0.0048	CcSEcCtD
Nafcillin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000478	0.0048	CcSEcCtD
Nafcillin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000478	0.0048	CcSEcCtD
Nafcillin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000476	0.00478	CcSEcCtD
Nafcillin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000476	0.00478	CcSEcCtD
Nafcillin—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000473	0.00475	CcSEcCtD
Nafcillin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00047	0.00472	CcSEcCtD
Nafcillin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000459	0.00461	CcSEcCtD
Nafcillin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000454	0.00456	CcSEcCtD
Nafcillin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000454	0.00456	CcSEcCtD
Nafcillin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000451	0.00453	CcSEcCtD
Nafcillin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000451	0.00453	CcSEcCtD
Nafcillin—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000449	0.00451	CcSEcCtD
Nafcillin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000443	0.00445	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000442	0.00444	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000442	0.00444	CcSEcCtD
Nafcillin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000437	0.00438	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000433	0.00435	CcSEcCtD
Nafcillin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000428	0.0043	CcSEcCtD
Nafcillin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000426	0.00428	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000419	0.00421	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.00421	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000418	0.0042	CcSEcCtD
Nafcillin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000415	0.00417	CcSEcCtD
Nafcillin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000415	0.00417	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000411	0.00412	CcSEcCtD
Nafcillin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000407	0.00409	CcSEcCtD
Nafcillin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000406	0.00407	CcSEcCtD
Nafcillin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000402	0.00404	CcSEcCtD
Nafcillin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000402	0.00404	CcSEcCtD
Nafcillin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.0004	0.00402	CcSEcCtD
Nafcillin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.0004	0.00402	CcSEcCtD
Nafcillin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000397	0.00399	CcSEcCtD
Nafcillin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000397	0.00399	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00398	CcSEcCtD
Nafcillin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.00394	CcSEcCtD
Nafcillin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000389	0.00391	CcSEcCtD
Nafcillin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.00387	CcSEcCtD
Nafcillin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000386	0.00387	CcSEcCtD
Nafcillin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000384	0.00386	CcSEcCtD
Nafcillin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000384	0.00386	CcSEcCtD
Nafcillin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000384	0.00386	CcSEcCtD
Nafcillin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000384	0.00386	CcSEcCtD
Nafcillin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000383	0.00384	CcSEcCtD
Nafcillin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000379	0.00381	CcSEcCtD
Nafcillin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000379	0.00381	CcSEcCtD
Nafcillin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000379	0.00381	CcSEcCtD
Nafcillin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000378	0.00379	CcSEcCtD
Nafcillin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000378	0.00379	CcSEcCtD
Nafcillin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000376	0.00378	CcSEcCtD
Nafcillin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000376	0.00378	CcSEcCtD
Nafcillin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000375	0.00377	CcSEcCtD
Nafcillin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.00366	CcSEcCtD
Nafcillin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.00364	CcSEcCtD
Nafcillin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.00364	CcSEcCtD
Nafcillin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.00359	CcSEcCtD
Nafcillin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000358	0.00359	CcSEcCtD
Nafcillin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000357	0.00359	CcSEcCtD
Nafcillin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00035	0.00352	CcSEcCtD
Nafcillin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00345	CcSEcCtD
Nafcillin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00345	CcSEcCtD
Nafcillin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.00339	CcSEcCtD
Nafcillin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00338	CcSEcCtD
Nafcillin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000332	0.00334	CcSEcCtD
Nafcillin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000332	0.00334	CcSEcCtD
Nafcillin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000325	0.00327	CcSEcCtD
Nafcillin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00326	CcSEcCtD
Nafcillin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000314	0.00316	CcSEcCtD
Nafcillin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.00315	CcSEcCtD
Nafcillin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.0031	CcSEcCtD
Nafcillin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000309	0.0031	CcSEcCtD
Nafcillin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00308	CcSEcCtD
Nafcillin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00308	CcSEcCtD
Nafcillin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00307	CcSEcCtD
Nafcillin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00307	CcSEcCtD
Nafcillin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000302	0.00304	CcSEcCtD
Nafcillin—Rash—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00301	CcSEcCtD
Nafcillin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00301	CcSEcCtD
Nafcillin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000299	0.003	CcSEcCtD
Nafcillin—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000294	0.00296	CcSEcCtD
Nafcillin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00293	CcSEcCtD
Nafcillin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000291	0.00292	CcSEcCtD
Nafcillin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.0029	CcSEcCtD
Nafcillin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.0029	CcSEcCtD
Nafcillin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000288	0.0029	CcSEcCtD
Nafcillin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000288	0.0029	CcSEcCtD
Nafcillin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000283	0.00284	CcSEcCtD
Nafcillin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.00274	CcSEcCtD
Nafcillin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000271	0.00272	CcSEcCtD
Nafcillin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000263	0.00264	CcSEcCtD
Nafcillin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000259	0.0026	CcSEcCtD
Nafcillin—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000253	0.0327	CbGpPWpGaD
Nafcillin—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000251	0.0324	CbGpPWpGaD
Nafcillin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.00226	CcSEcCtD
Nafcillin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000217	0.00218	CcSEcCtD
Nafcillin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000217	0.00218	CcSEcCtD
Nafcillin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000214	0.0276	CbGpPWpGaD
Nafcillin—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000214	0.00215	CcSEcCtD
Nafcillin—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000211	0.00212	CcSEcCtD
Nafcillin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.0021	CcSEcCtD
Nafcillin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000199	0.002	CcSEcCtD
Nafcillin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000199	0.002	CcSEcCtD
Nafcillin—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000197	0.00198	CcSEcCtD
Nafcillin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000195	0.0252	CbGpPWpGaD
Nafcillin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000194	0.025	CbGpPWpGaD
Nafcillin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.00195	CcSEcCtD
Nafcillin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000191	0.00192	CcSEcCtD
Nafcillin—Shock—Prednisone—chronic obstructive pulmonary disease	0.000188	0.00189	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000174	0.00175	CcSEcCtD
Nafcillin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.00167	CcSEcCtD
Nafcillin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.00166	CcSEcCtD
Nafcillin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00158	CcSEcCtD
Nafcillin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000156	0.00157	CcSEcCtD
Nafcillin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.00157	CcSEcCtD
Nafcillin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000152	0.00152	CcSEcCtD
Nafcillin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00152	CcSEcCtD
Nafcillin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00152	CcSEcCtD
Nafcillin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00015	0.0194	CbGpPWpGaD
Nafcillin—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000145	0.0187	CbGpPWpGaD
Nafcillin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000141	0.00141	CcSEcCtD
Nafcillin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00136	CcSEcCtD
Nafcillin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00131	CcSEcCtD
Nafcillin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000131	0.0169	CbGpPWpGaD
Nafcillin—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000123	0.0159	CbGpPWpGaD
Nafcillin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00122	CcSEcCtD
Nafcillin—Rash—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00121	CcSEcCtD
Nafcillin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00121	CcSEcCtD
Nafcillin—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000119	0.0153	CbGpPWpGaD
Nafcillin—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000118	0.0152	CbGpPWpGaD
Nafcillin—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000114	0.0147	CbGpPWpGaD
Nafcillin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00114	CcSEcCtD
Nafcillin—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.0144	CbGpPWpGaD
Nafcillin—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000109	0.0141	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000107	0.0138	CbGpPWpGaD
Nafcillin—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000105	0.0136	CbGpPWpGaD
Nafcillin—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.0133	CbGpPWpGaD
Nafcillin—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	9.9e-05	0.0128	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	9.5e-05	0.0123	CbGpPWpGaD
Nafcillin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	9.49e-05	0.0123	CbGpPWpGaD
Nafcillin—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	9.11e-05	0.0118	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	8.65e-05	0.0112	CbGpPWpGaD
Nafcillin—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	8.64e-05	0.0111	CbGpPWpGaD
Nafcillin—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	8.16e-05	0.0105	CbGpPWpGaD
Nafcillin—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	7.94e-05	0.0102	CbGpPWpGaD
Nafcillin—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	7.64e-05	0.00986	CbGpPWpGaD
Nafcillin—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	7.64e-05	0.00986	CbGpPWpGaD
Nafcillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	7.15e-05	0.00923	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	6.01e-05	0.00776	CbGpPWpGaD
Nafcillin—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	5.61e-05	0.00724	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	5.29e-05	0.00682	CbGpPWpGaD
Nafcillin—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	5.29e-05	0.00682	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	5.29e-05	0.00682	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	5.21e-05	0.00672	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	5.15e-05	0.00664	CbGpPWpGaD
Nafcillin—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	4.94e-05	0.00638	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	4.64e-05	0.00599	CbGpPWpGaD
Nafcillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	4.54e-05	0.00586	CbGpPWpGaD
Nafcillin—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	4.48e-05	0.00578	CbGpPWpGaD
Nafcillin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.27e-05	0.00551	CbGpPWpGaD
Nafcillin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.22e-05	0.00544	CbGpPWpGaD
Nafcillin—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	4.08e-05	0.00526	CbGpPWpGaD
Nafcillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	3.68e-05	0.00475	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	3.61e-05	0.00466	CbGpPWpGaD
Nafcillin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.46e-05	0.00447	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	3.32e-05	0.00428	CbGpPWpGaD
Nafcillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	3.3e-05	0.00426	CbGpPWpGaD
Nafcillin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	3.25e-05	0.0042	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.05e-05	0.00393	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.01e-05	0.00389	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	2.92e-05	0.00377	CbGpPWpGaD
Nafcillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	2.67e-05	0.00345	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	2.48e-05	0.00319	CbGpPWpGaD
Nafcillin—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	2.47e-05	0.00319	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.35e-05	0.00303	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.32e-05	0.003	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	2.27e-05	0.00293	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	2.23e-05	0.00287	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	2.23e-05	0.00287	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.14e-05	0.00276	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	2.12e-05	0.00274	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	2.12e-05	0.00274	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.11e-05	0.00273	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.09e-05	0.0027	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.08e-05	0.00269	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	1.95e-05	0.00252	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.94e-05	0.0025	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.93e-05	0.00249	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.91e-05	0.00247	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.84e-05	0.00237	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.81e-05	0.00234	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.63e-05	0.0021	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.61e-05	0.00207	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.5e-05	0.00193	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.48e-05	0.00191	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.48e-05	0.00191	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.42e-05	0.00183	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.4e-05	0.00181	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.26e-05	0.00162	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.14e-05	0.00147	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.06e-05	0.00136	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.81e-06	0.00127	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	9.54e-06	0.00123	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.87e-06	0.00114	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.57e-06	0.000977	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	7.36e-06	0.00095	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.07e-06	0.000912	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.84e-06	0.000883	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.21e-06	0.000672	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	5.15e-06	0.000665	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.8e-06	0.00062	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.7e-06	0.000607	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.02e-06	0.000519	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.98e-06	0.000513	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.63e-06	0.000468	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.61e-06	0.000466	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.56e-06	0.00046	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.34e-06	0.000431	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.32e-06	0.000428	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.15e-06	0.000406	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.79e-06	0.00036	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.75e-06	0.000355	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.56e-06	0.000331	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.43e-06	0.000313	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.14e-06	0.000276	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.05e-06	0.000264	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.65e-06	0.000213	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.58e-06	0.000204	CbGpPWpGaD
